n(g),n(g')-dimethyl-l-arginine has been researched along with Non-alcoholic Fatty Liver Disease in 6 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although impaired synthesis and/or bioavailability of nitric oxide are considered to contribute to insulin resistance and the progression of liver disease in nonalcoholic fatty liver disease, role of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, has not been examined." | 7.80 | Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. ( Chayama, K; Fukami, K; Hyogo, H; Ishitobi, T; Kimura, Y; Maeda, S; Nakahara, T; Okuda, S; Ueda, S; Yamagishi, S, 2014) |
| "Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease." | 5.38 | Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? ( Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S, 2012) |
| "Asymmetric dimethylguanidino valeric acid (ADGV), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are three arginine metabolites which have utility in the assessment of cardiovascular disease, renal disease and non-alcoholic fatty liver disease (NAFLD)." | 4.12 | Design and validation of an LC-MS/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma. ( Bonnitcha, P; Fitzpatrick, M; Ireland, A; Koay, YC; Nguyen, VL; O'Sullivan, J; Sullivan, D, 2022) |
| "Although impaired synthesis and/or bioavailability of nitric oxide are considered to contribute to insulin resistance and the progression of liver disease in nonalcoholic fatty liver disease, role of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, has not been examined." | 3.80 | Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. ( Chayama, K; Fukami, K; Hyogo, H; Ishitobi, T; Kimura, Y; Maeda, S; Nakahara, T; Okuda, S; Ueda, S; Yamagishi, S, 2014) |
| "Our data suggested that NAFLD is associated with endothelial dysfunction and increased earlier in patients with atherosclerosis compared to control subjects." | 1.39 | Assessment of endothelial function in patients with nonalcoholic fatty liver disease. ( Colak, Y; Coskunpinar, E; Doganay, L; Kahraman, OT; Mesci, B; Ozturk, O; Senates, E; Tuncer, I; Ulasoglu, C; Yesil, A; Yilmaz, Y, 2013) |
| "Nonalcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic syndrome (MetS) is closely associated with an increased risk of cardiovascular disease." | 1.39 | Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. ( Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Karslioglu, Y; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S, 2013) |
| "Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular disease." | 1.38 | Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? ( Aslan, F; Bagci, S; Dogru, T; Ercin, CN; Genc, H; Kara, M; Kurt, I; Ors, F; Sertoglu, E; Sonmez, A; Tapan, S, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnitcha, P | 1 |
| Sullivan, D | 1 |
| Fitzpatrick, M | 1 |
| Ireland, A | 1 |
| Nguyen, VL | 1 |
| Koay, YC | 1 |
| O'Sullivan, J | 1 |
| Boga, S | 1 |
| Alkim, H | 1 |
| Koksal, AR | 1 |
| Bayram, M | 1 |
| Ozguven, MB | 1 |
| Ergun, M | 1 |
| Neijmann, ST | 1 |
| Ozgon, G | 1 |
| Alkim, C | 1 |
| Dogru, T | 2 |
| Genc, H | 2 |
| Tapan, S | 2 |
| Ercin, CN | 2 |
| Ors, F | 2 |
| Aslan, F | 2 |
| Kara, M | 2 |
| Sertoglu, E | 2 |
| Bagci, S | 2 |
| Kurt, I | 2 |
| Sonmez, A | 2 |
| Colak, Y | 1 |
| Senates, E | 1 |
| Yesil, A | 1 |
| Yilmaz, Y | 1 |
| Ozturk, O | 1 |
| Doganay, L | 1 |
| Coskunpinar, E | 1 |
| Kahraman, OT | 1 |
| Mesci, B | 1 |
| Ulasoglu, C | 1 |
| Tuncer, I | 1 |
| Karslioglu, Y | 1 |
| Hyogo, H | 1 |
| Yamagishi, S | 1 |
| Maeda, S | 1 |
| Fukami, K | 1 |
| Ueda, S | 1 |
| Okuda, S | 1 |
| Nakahara, T | 1 |
| Kimura, Y | 1 |
| Ishitobi, T | 1 |
| Chayama, K | 1 |
6 other studies available for n(g),n(g')-dimethyl-l-arginine and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Design and validation of an LC-MS/MS method for simultaneous quantification of asymmetric dimethylguanidino valeric acid, asymmetric dimethylarginine and symmetric dimethylarginine in human plasma.
Topics: Arginine; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Fem | 2022 |
Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology.
Topics: Adult; Arginine; C-Reactive Protein; Case-Control Studies; Female; Humans; Inflammation; Insulin Res | 2015 |
Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
Topics: Adult; Arginine; Biomarkers; Carotid Artery Diseases; Carotid Intima-Media Thickness; Fatty Liver; H | 2012 |
Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
Topics: Adult; Arginine; Atherosclerosis; Brachial Artery; Carotid Arteries; Carotid Intima-Media Thickness; | 2013 |
Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Topics: Adiponectin; Adult; alpha-2-HS-Glycoprotein; Arginine; Atherosclerosis; Carotid Artery Diseases; Car | 2013 |
Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients.
Topics: Adult; Aged; Arginine; Fatty Liver; Female; Humans; Male; Middle Aged; Non-alcoholic Fatty Liver Dis | 2014 |